QUOTE AND NEWS
Benzinga  May 2  Comment 
Jefferies increases its price target from $15 to $19 on Wright Medical Group (NASDAQ: WMGI) as Q1 suggest early stages of progress, but reiterates its Hold rating on shares given that it is too early to assess whether it will continue....
Benzinga  May 2  Comment 
Wunderlich Securities reiterates its Hold rating and $16 price target on Wright Medical Group (NASDAQ: WMGI) in light of solid Q1 results, as well as concerns of increased costs due to strategic positioning. Wunderlich Securities notes,...
StreetInsider.com  May 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Wright+Medical+Group+%28WMGI%29+Tops+Q1+EPS+by+3c%3B+Guides+Above+for+FY+EPS/7390883.html for the full story.
Business Wire  May 1  Comment 
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market, today reported financial results for its first quarter ended March 31, 2012. Net
Business Wire  Apr 26  Comment 
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced today that it will be participating in the Bank of America Merrill Lynch 2012 Health Care Conference on Tuesday, May 15, 2012 at the Encore at Wynn
Business Wire  Apr 23  Comment 
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced today that it will be participating in the Deutsche Bank Health Care Conference on Monday, May 7, 2012 at the Intercontinental Hotel in Boston, MA.
Business Wire  Apr 12  Comment 
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Tuesday, May 1, 2012 at 3:30 p.m. Central Time to discuss the Company’s operating results for its first quarter ended March 31, 2012. Operating results
Benzinga  Mar 2  Comment 
Piper Jaffray lifts its price target on Overweight-rated Wright Medical (NASDAQ: WMGI) to $23 from $21 on insights from meetings with the company's management. Piper Jaffray says, "We have greater conviction after our day with management...
Business Wire  Mar 1  Comment 
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced the full commercial launch of the CLAW® II Polyaxial Compression Plating System featuring ORTHOLOC™ 3DSi Polyaxial Locking Screw Technology.
Forbes  Feb 24  Comment 
NII (NIHD) was downgraded today by JP Morgan (JPM) from overweight to neutral with a price target




 
TOP CONTRIBUTORS

Wright Medical Group, Inc. (WMGI) is a global orthopedic device company specializing in the design, manufacture, and marketing of reconstructive joint devices and bio-orthopedic materials. Reconstructive joint devices are used to replace knee, hip, and other joints that have deteriorated through disease or injury. Bio-orthopedic materials are used to replace damaged or diseased bones, and to stimulate natural bone growth. Wright Medical primarily operates through three divisions: Orthopedic Implants, Orthobiologic Products, and Other Products. Through these divisions, the company offers large joint implants for the hip and knee extremity implants for the hand, elbow, shoulder, foot, and ankle and both synthetic and tissue-based bone graft substitute materials. The company derives revenue entirely from product sales. In 2006, Orthopedic Implants (hips, knees, extremities) generated 77% of revenue, Orthobiologic Products generated 19%, and Other Products generated 4%. The company distributes its products in over 60 countries around the world, through a combination of direct sales personnel and a network of independent distributors. In 2006, domestic sales were 62% of total revenues, and international contributed the remaining 38%. The company's website is www.wmt.com.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki